Fig. 1.
Fig. 1. Overall survival from the time of inclusion in the LNH-87 trial. Comparison of patients with ALCL (n = 146) and patients with nonanaplastic diffuse large-cell lymphoma (n = 1,695); P = .0004.

Overall survival from the time of inclusion in the LNH-87 trial. Comparison of patients with ALCL (n = 146) and patients with nonanaplastic diffuse large-cell lymphoma (n = 1,695); P = .0004.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal